Lung Cancer Trial, Recruiting NCT07175077 Sponsor: University of Missouri-Columbia Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT07175077
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with small-cell lung cancer (a type of lung cancer), confirmed through a tissue sample test
  • People who have had a brain MRI scan within the past 4 weeks showing no signs of cancer spread to the brain or its surrounding membranes
  • People with no past history of cancer spreading to the brain or its surrounding membranes
  • People who have declined a type of brain radiation treatment called PCI (prophylactic cranial irradiation) and are willing to have regular brain MRI scans to monitor for any changes instead
  • People aged 18 or older
  • People with a general health and activity level rated between 0 and 2 on a standard medical scale, meaning they are able to care for themselves and carry out daily activities, even if they cannot do heavy physical work (confirm with trial site)
  • People who are able to tolerate a specialised type of MRI scanner called a 7T MRI

Who may not be able to join:

  • People who have metal implants, pacemakers, or other metal objects in their body that make MRI scanning unsafe
  • People who cannot receive a gadolinium contrast dye, which is a special liquid used during some MRI scans to make images clearer
  • People who currently have other cancers that have spread and are receiving active treatment
  • People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bo Lu, MD, CHAIR & PROFESSOR, DEPARTMENT OF RADIATION ONCOLOGY

Phone: 573-884-7488

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Missouri-Columbia
Registry
ClinicalTrials.gov
Start date
1 November 2025
Est. completion
1 September 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

7t MRI Brain Metastases Detection

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov